CDCP1 overexpression is associated with a specific immune-infiltrate driving prostate cancer progression

被引：0
|
作者：
Saponaro, M. [1 ]
D'Ambrosio, M. [2 ]
Schmidt, A. [1 ]
Kluemper, N. [1 ]
Hoelzel, M. [1 ]
Ritter, M. [1 ]
Alimonti, A. [2 ]
Alajati, A. [1 ]
机构：
[1] Univ Klinikum Bonn, Dept Urol, Bonn, Germany
[2] Inst Oncol Res, Dept Oncol, Bellinzona, Switzerland
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0420
引用
收藏
页码：S587 / S587
页数：1
相关论文
共 50 条
  • [1] CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
    Alajati, Abdullah
    D'Ambrosio, Mariantonietta
    Troiani, Martina
    Mosole, Simone
    Pellegrini, Laura
    Chen, Jingjing
    Revandkar, Ajinkya
    Bolis, Marco
    Theurillat, Jean-Philippe
    Guccini, Ilaria
    Losa, Marco
    Calcinotto, Arianna
    De Bernardis, Gaston
    Pasquini, Emiliano
    D'Antuono, Rocco
    Sharp, Adam
    Figueiredo, Ines
    Rodrigues, Daniel Nava
    Welti, Jonathan
    Gil, Veronica
    Yuan, Wei
    Vlajnic, Tatjana
    Bubendorf, Lukas
    Chiorino, Giovanna
    Gnetti, Letizia
    Torrano, Veronica
    Carracedo, Arkaitz
    Camplese, Laura
    Hirabayashi, Susumu
    Canato, Elena
    Pasut, Gianfranco
    Montopoli, Monica
    Ruschoff, Jan Hendrik
    Wild, Peter
    Moch, Holger
    De Bono, Johann
    Alimonti, Andrea
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2435 - 2450
  • [2] Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
    Zhao, Jinlu
    Mei, Jie
    Wang, Fengxu
    Zhao, Xinyuan
    Ren, Yi
    Zhao, Xingyu
    Li, Wang
    Gao, Erli
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [3] CDCP1 initiates tumorigenesis and cooperates with PTEN loss to promote senescence evasion and prostate cancer progression
    Alajati, A.
    Chen, J.
    Alimonti, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [4] Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
    Yang, Lifang
    Dutta, Sucharita M.
    Troyer, Dean A.
    Lin, Jefferson B.
    Lance, Raymond A.
    Nyalwidhe, Julius O.
    Drake, Richard R.
    Semmes, O. John
    [J]. ONCOTARGET, 2015, 6 (41) : 43743 - 43758
  • [5] Loss of CDCP1 triggers FAK activation in detached prostate cancer cells
    Pollan, Sara G.
    Teng, Pai-Chi
    Jan, Yu Jen
    Livingstone, Julie
    Huang, Cai
    Kim, Minhyung
    Mariscal, Javier
    Rodriguez, Maria
    Chen, Jie-Fu
    You, Sungyong
    DiVizio, Dolores
    Boutros, Paul C.
    Chan, Keith Syson
    Rasorenova, Olga
    Cress, Anne
    Spassov, Danislav
    Moasser, Mark
    Posadas, Edwin M.
    Freedland, Stephen J.
    Freeman, Michael R.
    Zheng, Jie J.
    Knudsen, Beatrice S.
    [J]. AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2021, 9 (04): : 350 - +
  • [6] FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation
    Cui, Yan-Hong
    Kim, Hyeonmi
    Lee, Minyoung
    Yi, Joo Mi
    Kim, Rae-Kwon
    Uddin, Nizam
    Yoo, Ki-Chun
    Kang, Jae Hyeok
    Choi, Mi-Young
    Cha, Hyuk-Jin
    Kwon, Ok-Seon
    Bae, In-Hwa
    Kim, Min-Jung
    Kaushik, Neha
    Lee, Su-Jae
    [J]. ONCOGENE, 2018, 37 (43) : 5794 - 5809
  • [7] Protease-activated CDCP1 as a marker for aggressive primary prostate cancer and castration resistance
    Merivirta, Ruusu-Maaria
    Lehto, Timo-Pekka
    Rannikko, Antti
    Mirtti, Tuomas
    Koistinen, Hannu
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [8] DKC1 overexpression associated with prostate cancer progression
    P Sieron
    C Hader
    J Hatina
    R Engers
    A Wlazlinski
    M Müller
    W A Schulz
    [J]. British Journal of Cancer, 2009, 101 : 1410 - 1416
  • [9] DKC1 overexpression associated with prostate cancer progression
    Sieron, P.
    Hader, C.
    Hatina, J.
    Engers, R.
    Wlazlinski, A.
    Mueller, M.
    Schulz, W. A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1410 - 1416
  • [10] FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation
    Yan-Hong Cui
    Hyeonmi Kim
    Minyoung Lee
    Joo Mi Yi
    Rae-Kwon Kim
    Nizam Uddin
    Ki-Chun Yoo
    Jae Hyeok Kang
    Mi-Young Choi
    Hyuk-Jin Cha
    Ok-Seon Kwon
    In-Hwa Bae
    Min-Jung Kim
    Neha Kaushik
    Su-Jae Lee
    [J]. Oncogene, 2018, 37 : 5794 - 5809
12345